These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 26422288)

  • 1. Pulmonary Functions in Children With Thalassemia Major.
    Ozyoruk D; Misirlioglu ED
    J Pediatr Hematol Oncol; 2015 Nov; 37(8):605-10. PubMed ID: 26422288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary functions in Egyptian children with transfusion-dependent β-thalassemia.
    Abd El Hakeem AA; Mousa SMO; AbdelFattah MT; AbdelAziz AO; Abd El Azeim SS
    Transfus Med; 2019 Feb; 29(1):55-60. PubMed ID: 30779248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-thalassemia and pulmonary function.
    Piatti G; Allegra L; Ambrosetti U; Cappellini MD; Turati F; Fiorelli G
    Haematologica; 1999 Sep; 84(9):804-8. PubMed ID: 10477453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of blood transfusion on cytokine profile and pulmonary function in patients with thalassemia major.
    Gülhan B; Yalçın E; Ünal Ş; Oğuz B; Özçelik U; Ersöz DD; Gümrük F; Kiper N
    Clin Respir J; 2016 Mar; 10(2):153-62. PubMed ID: 25069394
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary function test in transfusion-dependent β-thalassemia major patients: a pilot study.
    Alyasin S; Moghtaderi M; Amin R; Kashef S; Karimi M
    Pediatr Hematol Oncol; 2011 May; 28(4):329-33. PubMed ID: 21345079
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of iron overload and glomerular filtration rate estimated by cystatin C in patients with β-thalassemia major.
    Al-Khabori M; Bhandari S; Al-Rasadi K; Mevada S; Al-Dhuhli H; Al-Kemyani N; Daar S
    Hemoglobin; 2014; 38(5):365-8. PubMed ID: 25074643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum angiogenin level in sickle cell disease and beta thalassemia patients.
    Matter RM; Abdelmaksoud AA; Shams MA; Bebawy EK
    Pediatr Hematol Oncol; 2014 Feb; 31(1):50-6. PubMed ID: 24483841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary function tests in beta thalassemia.
    Arora M; Chandra J; Suri JC; Narayan S; Dutta AK
    Indian J Pediatr; 2001 Mar; 68(3):239-42. PubMed ID: 11338220
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary dysfunction in transfusion-dependent patients with thalassemia major.
    Carnelli V; D'Angelo E; Pecchiari M; Ligorio M; D'Angelo E
    Am J Respir Crit Care Med; 2003 Jul; 168(2):180-4. PubMed ID: 12738605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-thalassemia major: thin-section CT features and correlation with pulmonary function and iron overload.
    Khong PL; Chan GC; Lee SL; Au WY; Fong DY; Tsang KW; Ooi GC
    Radiology; 2003 Nov; 229(2):507-12. PubMed ID: 14595151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum ferritin levels and endocrinopathy in medically treated patients with β thalassemia major.
    Belhoul KM; Bakir ML; Saned MS; Kadhim AM; Musallam KM; Taher AT
    Ann Hematol; 2012 Jul; 91(7):1107-14. PubMed ID: 22281991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Restrictive effects of thalassemia on respiratory functions: One center experience.
    Ersoy GZ; Nain E; Ertekin M; Terzi O; Sasihuseyinoglu AS; Dikme G
    North Clin Istanb; 2023; 10(5):589-596. PubMed ID: 37829756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of splenectomy on iron balance in patients with β-thalassemia major: a long-term follow-up.
    Casale M; Cinque P; Ricchi P; Costantini S; Spasiano A; Prossomariti L; Minelli S; Frega V; Filosa A
    Eur J Haematol; 2013 Jul; 91(1):69-73. PubMed ID: 23581970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of genotype on endocrine complications in thalassaemia major.
    Skordis N; Michaelidou M; Savva SC; Ioannou Y; Rousounides A; Kleanthous M; Skordos G; Christou S
    Eur J Haematol; 2006 Aug; 77(2):150-6. PubMed ID: 16800840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and complications of thalassemia major in Guangxi, Southern China.
    Yin XL; Wu ZK; He YY; Zhou TH; Zhou YL; Zhang XH
    Pediatr Blood Cancer; 2011 Dec; 57(7):1174-8. PubMed ID: 21394896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal MRI and Ferritin Monitoring of Iron Overload in Chronically Transfused and Chelated Children With Sickle Cell Anemia and Thalassemia Major.
    Aubart M; Ou P; Elie C; Canniffe C; Kutty S; Delos V; Graffigne C; de Montalembert M; Brousse V
    J Pediatr Hematol Oncol; 2016 Oct; 38(7):497-502. PubMed ID: 27548334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Response to hydroxycarbamide in pediatric β-thalassemia intermedia: 8 years' follow-up in Egypt.
    El-Beshlawy A; El-Ghamrawy M; EL-Ela MA; Said F; Adolf S; Abdel-Razek AR; Magdy RI; Abdel-Salam A
    Ann Hematol; 2014 Dec; 93(12):2045-50. PubMed ID: 25062719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of pulmonary function impairments in patients with mucopolysaccharidoses--changes with age and treatment.
    Lin SP; Shih SC; Chuang CK; Lee KS; Chen MR; Niu DM; Chiu PC; Lin SJ; Lin HY
    Pediatr Pulmonol; 2014 Mar; 49(3):277-84. PubMed ID: 23401495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.